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Abstract A polymorphism in the autophagy gene Atg16l1 is associated with susceptibility to
inflammatory bowel disease (IBD); however, it remains unclear how autophagy contributes to
intestinal immune homeostasis. Here, we demonstrate that autophagy is essential for maintenance
of balanced CD4+ T cell responses in the intestine. Selective deletion of Atg16l1 in T cells in mice
resulted in spontaneous intestinal inflammation that was characterized by aberrant type 2
responses to dietary and microbiota antigens, and by a loss of Foxp3+ Treg cells. Specific ablation
of Atg16l1 in Foxp3+ Treg cells in mice demonstrated that autophagy directly promotes their
survival and metabolic adaptation in the intestine. Moreover, we also identify an unexpected role
for autophagy in directly limiting mucosal TH2 cell expansion. These findings provide new insights
into the reciprocal control of distinct intestinal TH cell responses by autophagy, with important
implications for understanding and treatment of chronic inflammatory disorders.
DOI: 10.7554/eLife.12444.001
Introduction
Crohn’s disease (CD) and ulcerative colitis (UC) are the two most common forms of inflammatory
bowel disease (IBD), characterized by chronic inflammation of the gastrointestinal tract. IBD is a com-
plex multifactorial disease that emerges on a background of many genetic and environmental factors
(Maloy and Powrie, 2011). In recent years, tremendous efforts have been undertaken to identify
the genetic factors that influence susceptibility to IBD. In particular, genome-wide association studies
(GWAS) and subsequent meta-analyses have identified over 150 distinct loci that influence IBD sus-
ceptibility, many of which have revealed novel pathways in disease pathogenesis (Van Limbergen
et al., 2014). Among these, a single-nucleotide polymorphism (SNP) in the essential macroautoph-
agy (hereafter called ’autophagy’) gene ATG16L1 was associated with an increased risk of CD
(Hampe et al., 2007; Rioux et al., 2007). A recent study showed that the IBD predisposing T300A
mutation in the coding region of ATG16L1 led to increased degradation of ATG16L1 protein and
reduced autophagy (Murthy et al., 2014), indicating that decreased autophagy may contribute to
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IBD development. Polymorphisms in several other autophagy-related genes, including IRGM, LRRK2
and SMURF1, are also linked to IBD susceptibility (Van Limbergen et al., 2014), suggesting that
changes in the autophagy pathway alter intestinal homeostasis and predispose to chronic intestinal
inflammation.
Autophagy is a highly conserved cellular process that targets cytoplasmic components for lyso-
somal degradation and maintains homeostasis by recycling damaged organelles and large cyto-
plasmic protein aggregates. Autophagy becomes particularly important during metabolic or
infectious stress (Mizushima, 2007). Atg16l1 forms an essential autophagy complex with Atg5 and
Atg12 that facilitates elongation of the initial isolation membrane that results in engulfment of the
cargo and formation of the autophagosome. Subsequent fusion with the lysosome facilitates degra-
dation and allows nutrient recycling (Mizushima et al., 2003). To identify the mechanisms through
which autophagy may regulate intestinal tissue homeostasis, it is essential to understand the func-
tional consequences of alterations in autophagy on both immune and tissue cells present in the gut.
To date, several studies have examined the role of autophagy and Atg16l1 in intestinal epithelial
cells and myeloid cells for intestinal homeostasis. In these studies, Atg16l1 was shown to play a role
in Paneth cell physiology, as well as in bacterial handling and regulation of inflammatory IL-1b secre-
tion by myeloid cells (Cadwell et al., 2008; Kuballa et al., 2008; Saitoh et al., 2008;
Plantinga et al., 2011). However, the role of Atg16l1 in intestinal adaptive immune responses has
not yet been addressed.
CD4+ T cells constitute the largest population of intestinal lymphocytes and are central mediators
of host protective and tolerogenic responses in the gut (Shale et al., 2013). In particular, thymus-
derived and peripherally induced Foxp3+ CD4+ regulatory T cells (tTreg and pTreg cells, respectively)
are indispensable in promoting tolerance toward commensal and dietary antigens and for the pre-
vention of aberrant effector T cell responses, including TH1, TH2 and TH17 cell responses
(Izcue et al., 2009). An imbalance between effector and regulatory CD4+ T cells can promote
chronic intestinal inflammation and accumulation of effector CD4+ T cells in the inflamed mucosa is a
cardinal feature of IBD (Abraham and Cho, 2009; Maloy and Powrie, 2011; Shale et al., 2013).
eLife digest The gut presents a puzzle to our immune system. Immune cells must rapidly
respond to antigens produced by harmful bacteria, but food and the beneficial bacteria that inhabit
the gut also produce antigens that our immune system must tolerate. Inappropriate immune
responses in the gut can lead to inflammatory bowel disease, a debilitating disease with no current
cure. We do not fully understand why these harmful inflammatory responses arise, but we know that
genetic factors are important. Mutations in genes that affect a process known as autophagy – a
pathway that breaks down and recycles unwanted material inside cells – make inflammatory bowel
disease more likely to develop, but exactly how they do so remains unclear.
T helper cells are crucial controllers of intestinal immune responses and changes in their numbers
and behaviour occur during inflammatory bowel disease. Kabat et al. explored how the autophagy
pathway affects these key immune cells in mice. Blocking autophagy in T cells altered the balance of
different types of T helper cells in the gut. A crucial population of regulatory T cells, which keep
inflammatory responses in check, was lost. At the same time, another population of T cells
expanded: the T helper 2 (TH2) cells that are responsible for driving allergies. As a result, the mice
developed intestinal inflammation and produced antibodies against gut bacteria and food.
Overall, Kabat et al.’s results show that autophagy defects can alter the balance of different types
of T cells in the gut, leading to inflammation in the intestine. These observations contribute to our
understanding of how genetic changes may influence susceptibility to inflammatory bowel disease.
They also suggest that drugs that activate autophagy could help to treat diseases associated with
changes in regulatory T cells or TH2 cells, including inflammatory bowel disease and allergies. It will
now be important to test this and to confirm whether similar changes in T cells are present in
humans that have mutations in autophagy genes.
DOI: 10.7554/eLife.12444.002
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Therefore, it is important to define factors that regulate aberrant CD4+ T cell responses in the gas-
trointestinal tract.
Previous studies utilizing mice with T-cell-specific deletion of essential autophagy genes (Atg3,
Atg5, Atg7, Beclin1) pointed to a key role of autophagy in T cell homeostasis, as these mice exhib-
ited decreased frequencies and numbers of CD4+ and CD8+ T cells and defects in T cell proliferation
in vitro (Pua et al., 2009; Stephenson et al., 2009; Jia and He, 2011; Kovacs et al., 2012). In addi-
tion, recent studies highlighted the importance of autophagy in the development of memory CD8+
T cells (Puleston et al., 2014; Xu et al., 2014; Schlie et al., 2015). However, the exact requirements
for autophagy during different stages of T cell activation and differentiation remain poorly under-
stood (Xu et al., 2014). Given that the gastrointestinal tract is a site of continuous immune activation
by external antigens and is therefore a challenging environment for the adaptive immune system, we
hypothesized that a selective defect in autophagy may affect intestinal T cell homeostasis.
We investigated the role of Atg16l1 in intestinal CD4+ T cells by generating mice that selectively
lack Atg16l1 in T cells. Here, we show that T-cell-specific deletion of Atg16l1 results in chronic intes-
tinal inflammation accompanied by increased humoral responses toward commensal and dietary
antigens. We further demonstrate that Atg16l1-deficiency has opposing effects on intestinal CD4+ T
cells subsets; markedly enhancing TH2 responses whilst decreasing Treg cell numbers. Through selec-
tive ablation of Atg16l1 in Treg cells, we established the importance of cell-intrinsic autophagy for
intestinal Treg cell homeostasis. Furthermore, through complementary in vivo approaches we show
that autophagy controls TH2 responses through two distinct mechanisms; through a cell-intrinsic
pathway and by promoting extrinsic regulation by Treg cells.
Results
Selective deletion of Atg16l1 in T cells results in spontaneous intestinal
pathology
To investigate the role of autophagy in intestinal T cell homoeostasis, mice carrying loxP-flanked
alleles of the essential autophagy gene Atg16l1 (Atg16l1fl/fl) (Hwang et al., 2012) were crossed with
CD4-Cre mice, generating Atg16l1fl/fl::CD4-Cre mice (hereafter denoted as Atg16l1DCD4) in which
Atg16l1 is selectively ablated in T cells from the double-positive stage of thymic development. To
verify functional deletion of Atg16l1 autophagy levels were analyzed by autophagosome formation
and LC3 lipidation. CD4+ T cells isolated from control Atg16l1fl/fl mice exhibited increased LC3+
autophagosome formation after activation, as measured by intracellular LC3 accumulation in the
presence of a lysosomal inhibitor (Figure 1A). In contrast, there was no increase in intracellular LC3
accumulation in CD4+ T cells from Atg16l1DCD4 mice (Figure 1A). To verify this finding using another
method, we assessed LC3 lipidation by Western blot analysis (Klionsky et al., 2012). Activated con-
trol Atg16l1fl/fl CD4+ T cells exhibited increased lipidated LC3 II levels in the presence of chloro-
quine, indicative of autophagy-mediated turnover of LC3 II after T cell activation (Figure 1B).
However, LC3 II levels in CD4+ T cells from Atg16l1DCD4 mice were barely affected by activation
(Figure 1B), confirming a block in autophagy.
Young Atg16l1DCD4 mice appeared normal, initially gained weight in a manner comparable to
Atg16l1fl/fl littermates and exhibited normal intestinal morphology (Figure 1C,F-H). However, from
around 5 months of age, Atg16l1DCD4 mice stopped gaining weight (Figure 1C), developed spleno-
megaly and lymphadenopathy (Figure 1D,E) and chronic intestinal pathology that progressed with
age (Figure 1F–I). Atg16l1DCD4 mice exhibited significant inflammation of both the small intestine
(SI) and colon, characterized by increased SI length, marked lengthening of crypts, shortening of villi
and epithelial hyperplasia (Figure 1F–I). Thus, T-cell-specific Atg16l1 deletion resulted in spontane-
ous intestinal inflammation and systemic immune activation.
Atg16l1 deficiency has opposing effects on intestinal Treg and TH2 cells
To characterize the effects of Atg16l1 on intestinal and systemic T cell homeostasis independently
from any confounding effects of ongoing tissue inflammation, we analyzed young (8–12 weeks old)
Atg16l1DCD4 mice before the onset of inflammatory pathology or systemic symptoms. Whilst thymic
T cell production was unperturbed in Atg16l1DCD4 mice (Figure 2—figure supplement 1A,B), fre-
quencies of CD4+ and CD8+ T cells in peripheral lymphoid organs were significantly decreased
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Figure 1. Aged Atg16l1DCD4 mice develop intestinal inflammation. (A) FACS analysis of LC3+ autophagosome formation in CD4+ T cells from cLP of
Atg16l1DCD4 and Atg16l1fl/fl mice after overnight activation with or without a-CD3 (5 mg/ml) and a-CD28 (1 mg/ml). (B) Western blot analysis of LC3
lipidation in naı¨ve splenic CD4+ T cells isolated from Atg16l1DCD4 mice and Atg16l1fl/fl mice after 3hr activation with a-CD3 (5 mg/ml) and a-CD28 (1 mg/
ml) with or without chloroquine (CQ, inhibitor of lysosomal degradation, 50 mM). (C) Weight curves of Atg16l1DCD4 and Atg16l1fl/fl littermates. (D)
Representative images of spleens and mesenteric lymph nodes (mLN) from aged Atg16l1DCD4 and Atg16l1fl/fl littermates and (E) spleen weights of
young and aged Atg16l1DCD4 and Atg16l1fl/fl littermates. (F,H) Representative photomicrographs of haemotoxilin and eosin (H&E) stained sections of (F)
jejunum and (H) mid-colon from young and aged Atg16l1DCD4 and Atg16l1fl/fl littermates, scale bar 150 mm. (G,I) Quantification of (G) SI lengths and (I)
mid-colon crypt lengths in aged Atg16l1DCD4 and Atg16l1fl/fl littermates. Data are representative of at least three independent experiments (A-E, F, H)
or combined from two (G) or three (I) independent experiments, with at least 3 mice per group. Data shown as mean ± s.e.m (A,C). Each dot represents
an individual mouse and horizontal bars denote means (E,G). In (I) each dot represents an individual crypt measurement and horizontal bars denote
Figure 1 continued on next page
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compared to Atg16l1fl/fl littermates (Figure 2A and Figure 2—figure supplement 1C). Furthermore,
we observed significant decreases in intestinal T cell frequencies and numbers in the cLP and SI LP
of Atg16l1DCD4 mice (Figure 2A and Figure 2—figure supplement 1D). As CD4+ T cells are the
main drivers and regulators of chronic intestinal inflammation (Shale et al., 2013), we focused subse-
quent analyses on CD4+ T cells.
Despite reduced numbers of T cells, Atg16l1DCD4 mice developed exacerbated disease in a CD4+
T cell-mediated model of IBD, indicating that Atg16l1-deficient CD4+ T cells are capable of driving
intestinal inflammation (Figure 2—figure supplement 2). Analysis of the effector CD4+ T cell com-
partment in Atg16l1DCD4 mice revealed that frequencies of colonic TH1 (IFN-g
+) and TH17 (IL-17A
-
+) populations were comparable in young Atg16l1DCD4 mice and Atg16l1fl/fl littermates (Figure 2B,
D), although, due to decreased colonic CD4+ T cell numbers, total TH1 and TH17 numbers were sig-
nificantly decreased (Figure 2C). Conversely, both frequencies and total numbers of TH2 (IL-13
+)
cells were significantly increased in cLP of young Atg16l1DCD4 mice (Figure 2B–D). These IL-13-pro-
ducing cells were bona fide TH2 cells, as they co-expressed the lineage-specifying transcription fac-
tor Gata3 (Figure 2D,E). Interestingly, TH2 cell accumulation was primarily observed in the intestinal
mucosa of Atg16l1DCD4 mice, as TH2 cell frequencies were only marginally increased in the mLN and
remained unchanged in the spleen (Figure 2E). However, the functional consequences of TH2 expan-
sion extended beyond the intestine, as Atg16l1DCD4 mice had increased frequencies of eosinophils
in both the spleen and mLN and elevated serum levels of mast cell protease 1 (MCPT-1), a marker of
intestinal mast cell activation (Figure 2—figure supplement 3A,B).
As Foxp3+ Treg cells play a non-redundant role in control of effector T cells and the development
of intestinal inflammation (Izcue et al., 2009), we hypothesized that alterations in Tregs might under-
lie the spontaneous intestinal pathology that developed in aged Atg16l1DCD4 mice. Indeed, we
found that the frequencies of intestinal Foxp3+ Treg cells in young Atg16l1
DCD4 mice were severely
reduced, both in the SI and cLP (Figure 2F,G). Taking into account the decreased frequencies of
CD4+ T cells in Atg16l1DCD4 mice (Figure 2A), this equated to a reduction in Treg cell numbers by
around 10-fold in the colonic LP and 4-fold in SI LP (Figure 2—figure supplement 4A). In contrast,
thymic development of Foxp3+ Treg cells was not diminished in young Atg16l1
DCD4 mice (Figure 2—
figure supplement 4B), and we observed only minor, though significant, reductions in the frequen-
cies and absolute numbers of Foxp3+ Treg cells in the spleen and mLN of Atg16l1
DCD4 mice com-
pared with Atg16l1fl/fl littermates (Figure 2G and Figure 2—figure supplement 4A). Thus, Atg16l1-
deficiency profoundly affected the maintenance of Foxp3+ Treg cells in the periphery, particularly
within the intestinal mucosa. Expression of neuropilin-1 (Nrp1) and Helios, putative markers pro-
posed to distinguish pTreg and tTreg cells, were found at comparable levels on intestinal Foxp3
+ Treg
cells from Atg16l1fl/fl and Atg16l1DCD4 mice, suggesting that the local environment, rather than site
of Treg induction, primarily dictates the requirement for autophagy in Treg cells (Figure 2—figure
supplement 4C,D). Assessment of how Atg16l1-deficiency affected intestinal Foxp3+ Treg cell phe-
notype showed that impaired autophagy significantly increased expression of effector TH cytokines
in Treg cells from cLP and SI LP (Figure 2—figure supplement 4E). We also found that cLP Treg cells
from young Atg16l1DCD4 mice showed higher expression of CD103 and CTLA-4, but showed
decreased expression of the activation markers CD25, CD69, and the terminal differentiation marker
KLRG-1 (Cheng et al., 2012) (Figure 2—figure supplement 4F). In addition, intestinal Treg cells
from young Atg16l1DCD4 mice had significantly increased expression of Ki67 and higher levels of
phosphorylated S6, suggesting that the majority were in cell cycle (Figure 2—figure supplement
4G–I). Taken together, these results identify a crucial role for autophagy in the maintenance and
functional regulation of intestinal Treg cells.
Overall, these results demonstrate that selective ablation of Atg16l1 in T cells led to a decrease in
Foxp3+ Treg cells and selective expansion of TH2 cells that preceded the onset of overt pathology. In
addition, these perturbations in TH cell subsets were largely limited to the mucosal environment.
Figure 1 continued
means. Statistical significance was determined using two-way analysis of variance (ANOVA) with Bonferroni’s correction for multiple comparisons (C) or
the Mann–Whitney test (E,G,I), **p<0.01; ***p<0.001. SI LP– small intestine lamina propria, cLP – colonic lamina propria. Young mice: 8–12 weeks old,
aged mice >5 months old.
DOI: 10.7554/eLife.12444.003
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Figure 2. Atg16l1DCD4 mice exhibit reciprocal dysregulation of intestinal TH2 and Treg cells before the onset of intestinal inflammation. (A) Frequencies
of CD4+ T cells as a proportion of live cells in young Atg16l1DCD4 and Atg16l1fl/fl littermates. (B) Frequencies and (C) total numbers of IFN-g+ TH1, IL-
17A+ TH17 and IL-13
+ TH2 cells isolated from cLP of young Atg16l1
DCD4 and Atg16l1fl/fl littermates (gated on CD4+ T cells). (D) Representative FACS
plots of Gata3 and IL-13 (top) or IFN-g and IL-17A (bottom) expression by cLP CD4+ T cells isolated from young Atg16l1DCD4 and Atg16l1fl/fl littermates
(gated on CD4+ TCRb+ Foxp3- live cells). (E) Frequencies of Gata3+ CD4+ T cells in young Atg16l1DCD4 and Atg16l1fl/fl littermates (gated on CD4+
TCRb+ Foxp3- cells). (F) Representative FACS plots and (G) frequencies of Foxp3+ Treg cells in young Atg16l1
DCD4 and Atg16l1fl/fl littermates (gated on
CD4+ TCRb+ cells). Data are combined from three or more independent experiments with at least two mice per group (A,B, D, E, G) or are
representative of four independent experiments with at least four mice per group (D, F). Each dot represents an individual mouse and horizontal bars
denote means. Numbers indicate percentage of cells in gates or quadrants. Statistical significance was determined using the Mann–Whitney test,
*p<0.05; **p<0.01; ***p<0.001. SI LP– small intestine lamina propria, cLP – colonic lamina propria. Young mice: 8–12 weeks old.
Figure 2 continued on next page
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Atg16l1DCD4 mice exhibit elevated type 2 humoral responses to
environmental antigens
We next assessed whether dysregulation in the intestinal Treg and TH2 compartment in Atg16l1
DCD4
mice affected humoral responses. While at the limit of detection in Atg16l1fl/fl controls, serum IgE
concentrations were significantly elevated in young Atg16l1DCD4 mice and increased further as the
mice aged (Figure 3A). Furthermore, levels of serum IgA and IgG1 in young Atg16l1
DCD4 mice were
also significantly elevated relative to Atg16l1fl/fl littermates (Figure 3—figure supplement 1A) and
again increased as the Atg16l1DCD4 mice aged (Figure 3B). In contrast, levels of isotypes not associ-
ated with TH2 help were identical in aged Atg16l1
DCD4 mice and Atg16l1fl/fl littermates (Figure 3B).
Thus, there was a progressive dysregulation of TH2-associated antibody responses in Atg16l1
DCD4
mice. Consistent with these elevated humoral responses, young Atg16l1DCD4 mice had higher fre-
quencies of germinal center (GC), memory B cells and plasma cells in the spleen and mLN compared
to Atg16l1fl/fl littermates (Figure 3—figure supplement 1B) and markedly enlarged Peyer’s patches
were observed in aged Atg16l1DCD4 mice (Figure 3C).
Multiple studies have demonstrated the critical role played by Foxp3+ Treg cells in immune toler-
ance to dietary and microbial antigens within the intestine. Furthermore, changes in intestinal Treg
and TH2 responses are associated with food hypersensitivities (Berin and Sampson, 2013). We
hypothesized that the aberrant humoral responses in Atg16l1DCD4 mice might be directed against
luminal antigens. Soy is the main protein source in chow, and we detected high levels of anti-soy
IgG1 and IgA in sera from aged Atg16l1
DCD4 mice, whereas these responses were undetectable in
control Atg16l1fl/fl littermates (Figure 3D). By contrast, we only detected marginal levels of soy-spe-
cific IgG2b or IgG2c in aged Atg16l1
DCD4 sera (Figure 3D). Importantly, elevated anti-soy IgG1 and
IgA antibodies were already present in sera from young Atg16l1DCD4 mice, before the onset of intes-
tinal inflammation (Figure 3—figure supplement 1C). Despite the very high levels of total serum
IgE in aged Atg16l1DCD4 mice, we did not detect elevated levels of anti-soy IgE (data not shown).
The absence of soy-specific IgE could be due to the inhibiting effects of persistent exposure to high-
dose antigens on IgE responses (Sudowe et al., 1997; Riedl et al., 2005). Therefore, to test
whether an IgE response was mounted during transient exposure to low-dose dietary antigens, we
fed young Atg16l1DCD4 and Atg16l1fl/fl mice with ovalbumin (OVA), either alone or in combination
with the mucosal adjuvant cholera toxin (CT). As expected, anti-OVA IgE responses were undetect-
able in control Atg16l1fl/fl mice fed OVA alone and were only marginally increased by co-administra-
tion of CT (Figure 3E). In contrast, Atg16l1DCD4 mice exhibited significantly elevated levels of anti-
OVA IgE after being fed OVA alone and developed >10-fold higher levels of OVA-specific IgE after
feeding of OVA with CT (Figure 3E). Together, these results indicate that Atg16l1DCD4 mice dis-
played aberrant TH2-associated antibody responses towards otherwise innocuous dietary protein
antigens.
Besides food antigens, the intestinal lumen harbors vast quantities of commensal-derived anti-
gens. Thus, we measured antibodies directed against the flagellin antigen CBir1, produced by com-
mensal bacteria belonging to Clostridia cluster XIVa, as antibodies against flagellin are readily
detected in sera of IBD patients (Lodes et al., 2004). We detected significantly higher levels of
CBir1-specific IgG1 and IgA in the serum of aged Atg16l1
DCD4 mice compared to control Atg16l1fl/fl
littermates, whereas anti-CBir1 IgG2b and IgG2c levels were comparable (Figure 3F). Furthermore,
CBir1-specific IgG1 and IgA were already detectable in young Atg16l1
DCD4 mice (data not shown). In
Figure 2 continued
DOI: 10.7554/eLife.12444.004
The following figure supplements are available for figure 2:
Figure supplement 1. Characterization of immune cell compartments in young Atg16l1DCD4mice.
DOI: 10.7554/eLife.12444.005
Figure supplement 2. Atg16l1DCD4 mice have increased susceptibility to T-cell-mediated experimental IBD.
DOI: 10.7554/eLife.12444.006
Figure supplement 3. Elevated type 2 innate responses in Atg16l1DCD4 mice.
DOI: 10.7554/eLife.12444.007
Figure supplement 4. Characterization of Atg16l1-deficient Treg cells.
DOI: 10.7554/eLife.12444.008
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contrast, increased TH2 cell-associated antibody responses were not mounted in young Atg16l1
DCD4
mice following oral infection either with the Gram-negative bacterium Helicobacter hepaticus or with
the nematode parasite Trichuris muris (Figure 3—figure supplement 1D,E). Taken together, these
results indicate that the abnormal TH2-associated antibody responses observed in Atg16l1
DCD4 mice
preceded the development of overt inflammation and were selectively induced towards commensal
microbiota and dietary antigens.
Figure 3. Atg16l1DCD4 mice develop elevated TH2-associated antibodies against intestinal luminal antigens. (A) Serum IgE concentrations in cohorts of
young and aged Atg16l1DCD4 and Atg16l1fl/fl littermates were measured by ELISA. (B) Serum antibody IgG1, IgG2b, IgG2c, IgA and IgM isotype levels in
aged Atg16l1DCD4 and Atg16l1fl/fl littermates were measured by ELISA. (C) Representative photomicrographs of H&E stained sections of Peyer’s patch
(PP) in the SI (jejunum) of aged Atg16l1DCD4 and Atg16l1fl/fl littermates, scale bar 150 mm. (D) Serum levels of Soy-specific IgA, IgG1, IgG2b, IgG2c
antibodies in aged Atg16l1DCD4 and Atg16l1fl/fl littermates were measured by ELISA. (E) Young Atg16l1DCD4 and Atg16l1fl/fl littermates were fed with
ovalbumin (OVA) alone or with cholera toxin (CT) as described in methods and levels of OVA-specific serum IgE were measured 8 weeks after first
challenge by ELISA. (F) Levels of CBir1-specific IgA, IgG1, IgG2b and IgG2c antibodies in serum of aged Atg16l1
DCD4 and Atg16l1fl/fl littermates
were measured by ELISA, serum was diluted 50x. Data are representative from at least two independent experiments with at least three mice per group
(A-D) or combined from two (E) or three (F) independent experiments with at least three mice per group. Each dot represents an individual mouse and
horizontal bars denote means (A,D,E,F). Serum isotype levels are shown as mean ± s.e.m (B). Statistical significance was determined using the Mann–
Whitney test (A,D-F) or two-way analysis of variance (ANOVA) with Bonferroni’s correction for multiple comparisons (B), *p<0.05; **p<0.01; ***p<0.001.
SI – small intestine. Young mice: 8–12 weeks old, aged mice > 5 months old.
DOI: 10.7554/eLife.12444.009
The following figure supplement is available for figure 3:
Figure supplement 1. Dysregulated humoral responses in young Atg16l1DCD4 mice.
DOI: 10.7554/eLife.12444.010
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Figure 4. Atg16l1 promotes survival of Treg cells and limits TH2 cell survival. (A,B) Atg16l1
DCD4 or Atg16l1fl/fl naı¨ve CD4+ T cells were cultured in TH0,
Treg, or TH2 polarizing conditions for 48 hr and analyzed by FACS. Representative FACS plots show (A) Foxp3 and (B) Gata3 expression (gated on CD4
+
TCRb+ T cells). (C) Frequencies of Treg cells (Foxp3
+) and TH2 cells (Gata3
+) arising from Atg16l1DCD4 or Atg16l1fl/fl naı¨ve CD4+ T cells cultured in Treg or
TH2 polarizing conditions for 5 days. (D) Atg16l1
DCD4 or Atg16l1fl/fl Treg cells were cultured with anti-CD3 (3 mg/ml) and anti-CD28 (1 mg/ml) for 48 hr,
then maintained in the presence of IL-4 and IL-13 for a further 5 days before FACS analysis of Foxp3 and CD25 expression of live CD4+ T cells. (E,F)
Naı¨ve Atg16l1DCD4 or Atg16l1fl/fl CD4+ T cells were cultured with (E) 1 mg/ml or (F) 5 mg/ml anti-CD3 plus anti-CD28 (1 mg/ml) for 48 hr in Treg or TH2
polarizing conditions, then maintained in polarizing conditions for a further 5 days before FACS analysis of cell survival. Histograms show gates and
frequencies of live CD4+ T cells. (G) Representative FACS plots of viability dye and Annexin V staining of Treg cells and TH2 cells from the cLP of young
Atg16l1DCD4 and Atg16l1fl/fl littermates, gated on CD4+ TCRb+ Foxp3+ (left panel), or CD4+ TCRb+ Gata3+ (right panel). Data are representative from
two (D,G) or three independent experiments (A,B,E,F), or are combined from three independent experiments (C). Each dot represents an individual cell
culture (C) or data are shown as mean ± s.e.m (A,B,D-F). Numbers indicate percentage of cells in quadrants (G). cLP – colonic lamina propria. Young
mice: 8–12 weeks old.
DOI: 10.7554/eLife.12444.011
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Figure 5. Autophagy contributes to the elevated TH2 responses in Atg16l1
DCD4 mice in a cell-intrinsic manner.
Young Atg16l1DCD4 mice (CD45.2+) were adoptively transferred with 4-5x106 naı¨ve WT CD4+ T cells (CD45.1+) and
analyzed 3 months later. (A) Frequencies of WT (CD45.1+) and Atg16l1-deficient (CD45.2+) CD4+ T cells in the
spleen, mLN and cLP. (B) Frequencies of WT (CD45.1+) and Atg16l1-deficient (CD45.2+) Foxp3+ Treg cells in the
spleen, mLN and cLP (gated on CD4+ TCRb+ T cells). (C) Representative FACS plots showing gating of WT
(CD45.1+) and Atg16l1-deficient (CD45.1-) CD4+ T cells and expression of IL-13 (TH2), IFN-g (TH1) and IL-17A (TH17)
in the cLP (gated on CD4+ TCRb+ Foxp3- T cells). (D) Frequencies of WT (CD45.1+) and Atg16l1-deficient
(CD45.2+) TH2 (IL-13
+), TH1 (IFN- g
+) and TH17 (IL-17A
+) cells among CD4+ TCRb+ Foxp3- T cells in the cLP. (E)
Frequencies of WT (CD45.1+) and Atg16l1-deficient (CD45.2+) Gata3+ CD4+ T cells in the spleen, mLN and cLP
(gated on CD4+ TCRb+ Foxp3- T cells). (F) SI lengths and (G) representative photomicrographs of jejunum of
control untreated Atg16l1fl/fl or Atg16l1DCD4 littermates and reconstituted Atg16l1DCD4 mice, scale bar 150 mm. (H)
Serum IgE concentrations in control untreated Atg16l1fl/fl or Atg16l1DCD4 littermates and adoptively transferred
Figure 5 continued on next page
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Atg16l1 differentially regulates survival of TH2 and Treg cells
Given apparent opposing effects of Atg16l1 deficiency on TH2 and Treg cells, we questioned whether
the disruption of autophagy pathway affects the differentiation of these T cell subsets. We found
that, under TH2 or Treg polarizing conditions, differentiation of naı¨ve CD4
+ T cells isolated from
Atg16l1DCD4 or Atg16l1fl/fl littermates toward the Gata3+ TH2 or Foxp3
+ Treg cell phenotype was
comparable (Figure 4A–C). As TH2 cytokines can negatively affect Treg differentiation and stability
(Dardalhon et al., 2008; Feng et al., 2014), it was possible that outgrowth of TH2 cells may also
have contributed to the loss of intestinal Treg in Atg16l1
DCD4 mice. We therefore isolated Foxp3+
Treg cells from Atg16l1
DCD4 and Atg16l1fl/fl littermates and activated them in vitro in the presence of
IL-4 and IL-13. However, we did not find any evidence of Treg instability, as expression of Foxp3 and
CD25 remained equally high in Atg16l1-deficient and WT Treg cells (Figure 4D).
We therefore examined whether autophagy deficiency influenced the survival of TH2 or Foxp3
+
Treg cells. Thus, naı¨ve CD4
+ T cells isolated from Atg16l1DCD4 or Atg16l1fl/fl littermates were acti-
vated for 48 hr with anti-CD3 and anti-CD28 antibodies and then rested for 5 days. Cells were kept
in TH2 or Treg polarizing conditions throughout the experiment. Following activation with different
concentrations of anti-CD3 antibody, Atg16l1-deficient TH2 cells exhibited comparable or improved
survival relative to WT TH2 cells (Figure 4E,F). In contrast, there was a 50–75% decrease in survival
of Atg16l1-deficient Treg cells when compared to Atg16l1-sufficient Treg cells activated under the
same conditions (Figure 4E,F). To establish whether autophagy-deficient Treg and TH2 cells exhib-
ited similarly distinct survival profiles in vivo CD4+ T cells isolated from cLP of Atg16l1DCD4 or
Atg16l1fl/fl littermates were stained with a viability dye and Annexin V. We observed that an
increased proportion of Atg16l1-deficient intestinal Treg cells were dead or dying compared to WT
Treg cells (Figure 4G). In contrast, Atg16l1-deficiency had no negative effect on the viability of intes-
tinal TH2 cells, which was comparable to WT controls (Figure 4G). Together, these results indicate
that Atg16l1-deficiency does not impair the differentiation or stability of Treg cells and does not pro-
mote differentiation towards the TH2 lineage. However, autophagy differentially impacts on the sur-
vival of mucosal Treg and TH2 cells.
Autophagy regulates intestinal TH2 responses in a cell-intrinsic manner
As pTreg cells are required to control TH2 responses at mucosal sites (Mucida et al., 2005;
Curotto de Lafaille et al., 2008; Josefowicz et al., 2012), we examined whether the enhanced TH2
phenotype in Atg16l1DCD4 mice could be corrected by reconstitution of the intestinal Foxp3+ Treg
compartment. We restored the pTreg population in young Atg16l1DCD4 mice at the age of 10–12
weeks, before the onset of intestinal pathology, through adoptive transfer of congenic WT naı¨ve
CD45.1+ CD4+ T cells. Recipients were sacrificed 3 months later, when control Atg16l1DCD4 litter-
mates had developed intestinal inflammation. We detected CD45.1
+
donor CD4+ T cells in all adop-
tively transferred Atg16l1DCD4 mice, but the level of reconstitution varied by the organ examined. In
reconstituted Atg16l1DCD4 mice, donor WT CD4+ T cells accounted for 37 ± 5% of total CD4+ T cells
in spleen and 18 ± 2% in mLN, whereas in the cLP they represented 56 ± 4% (Figure 5A). Thus,
autophagy-deficient CD4+ T cells had a survival disadvantage when compared to WT CD4+ T cells
within the intestinal mucosa. Overall, adoptive transfer of WT naı¨ve CD4+ T cells restored the total
Figure 5 continued
Atg16l1DCD4 mice were measured by ELISA. Data are representative of two independent experiments with at least
four mice per group (A-E,G) or combined from two independent experiments (F,H). Each dot represents cells
coming from the donor or the hosts within the individual transferred mouse (A,B,D,E) or each dot represents an
individual mouse (F,H), horizontal bars denote mean. Numbers indicate percentage of cells in gates. Statistical
significance was determined using the Mann–Whitney test, *p<0.05; **p<0.01. mLN - mesenteric lymph nodes,
cLP – colonic lamina propria. Young mice: 10–12 weeks old.
DOI: 10.7554/eLife.12444.012
The following figure supplement is available for figure 5:
Figure supplement 1. Reconstitution of intestinal CD4+ T cell compartments in adoptively transferred Atg16l1DCD4
mice.
DOI: 10.7554/eLife.12444.013
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frequencies of CD4+ T cells in the cLP to levels comparable to control Atg16l1fl/fl mice (Figure 5—
figure supplement 1A).
When we examined Foxp3+ Treg cells, the survival advantage conferred by autophagy was even
more apparent, with around 50% of the donor WT naı¨ve CD45.1+ T cells developing into Foxp3+
pTreg cells in spleen, mLN and cLP of Atg16l1
DCD4 recipients. As a result, the majority of Foxp3+ Treg
cells were of WT donor origin (67 ± 5% in spleen, 59 ± 4% in mLN and 80 ± 5% in cLP) (Figure 5B).
Thus, adoptive transfer of WT-naı¨ve CD4+ T cells resulted in efficient reconstitution of Foxp3+ pTreg
cells in Atg16l1DCD4 mice; the total frequencies and numbers of Treg cells within the cLP of trans-
ferred mice were comparable with control Atg16l1fl/fl mice (Figure 5—figure supplement 1B). As
such, we could utilize this system to determine whether excessive TH2 cell accumulation in
Atg16l1DCD4 mice was due to impaired mucosal pTreg cells or to a cell-intrinsic effect of Atg16l1-defi-
ciency in TH2 cells.
When we analyzed the frequencies of TH2 cells in the cLP of reconstituted Atg16l1
DCD4 mice, we
observed significantly higher frequencies of Gata3+ IL-13+ TH2 cells among Atg16l1-deficient
CD45.2+ CD4+ T cells compared with the WT donor CD45.1+ CD4+ T cells (Figure 5C–E). Indeed,
frequencies of IL-13+ Atg16l1-deficient CD4+ T cells in the cLP of pTreg-reconstituted mice were
comparable to those found in untreated Atg16l1DCD4 littermates (Figure 5C,D). In contrast, there
was no difference in TH17 cell frequencies between Atg16l1-deficient CD45.2
+ and WT CD4+ T cells,
and there was a significant decrease in TH1 frequencies among Atg16l1-deficient CD4
+ T cells
(Figure 5C,D). In line with these observations, adoptively transferred Atg16l1DCD4 mice had compa-
rable total frequencies and numbers of TH2 cells as observed in untreated Atg16l1
DCD4 mice (Fig-
ure 5—figure supplement 1C). Thus, provision of WT pTreg cells did not rescue the increased TH2
phenotype of Atg16l1-deficient CD4+ T cells, indicating that autophagy directly regulates TH2 cells
through a cell-intrinsic mechanism. Consistent with this finding, Atg16l1DCD4 mice reconstituted with
WT pTreg cells still developed intestinal pathology and elevated serum IgE levels comparable to
those present in untreated Atg16l1DCD4 littermates (Figure 5F–H).
Autophagy is essential for Treg cell homeostasis and control of effector
T cell responses in the gut
Given that Atg16l1-deficiency significantly reduced the number of intestinal Treg cells in Atg16l1
DCD4
mice, we hypothesized that Treg cells may be particularly reliant on autophagy compared to other
subsets of CD4+ T cells. Indeed, in WT mice we found that levels of autophagy were significantly
higher in Foxp3+ Treg cells compared to Foxp3
- CD4+ T cells, both constitutively and after TCR acti-
vation (Figure 6A,B). Together with our observations of impaired survival of Atg16l1-deficient
Foxp3+ Treg cells (Figure 4E–G), this suggested an important cell-intrinsic role for autophagy in the
maintenance of Treg cells. This hypothesis was further strengthened by analyses of mixed bone mar-
row (BM) chimeras where irradiated Rag1-/- mice were reconstituted with a 1:1 mixture of BM cells
from Atg16l1DCD4 mice and congenic WT C57BL/6mice (Figure 6—figure supplement 1A). In this
setting, the reconstitution of CD4+ T cells was severely hampered in the absence of functional
autophagy and this deficiency was most pronounced in the Treg compartment of the spleen and cLP
(Figure 6—figure supplement 1B–E), confirming that Atg16l1-deficiency decreases the ability of
Foxp3+ Treg cells to compete with WT Treg cells in a cell-intrinsic manner.
To definitively assess the cell-intrinsic requirement for autophagy in Foxp3+ Treg cells we crossed
Atg16l1fl/fl mice with mice expressing a YFP-Cre from the Foxp3 locus (Foxp3Cre mice)
(Rubtsov et al., 2008), generating Atg16l1fl/fl::Foxp3Cre mice (hereafter denoted as Atg16l1DFoxp3)
in which Atg16l1 is selectively ablated in Foxp3+ Treg cells. These mice allowed us to analyze the
consequences of a lack of autophagy in Treg cells in the context of autophagy-competent CD4
+ T
effector cells. As expected, Atg16l1DFoxp3 mice showed a significant reduction of Atg16l1 expression
in Foxp3+ Treg cells, but not in CD4
+ Foxp3- T cells (Figure 6—figure supplement 2A). Although
Atg16l1DFoxp3 mice appeared normal in early life, at around 5 months of age they developed a
severe spontaneous inflammatory disease characterized by progressive weight loss, splenomegaly,
lymphadenopathy and leukocyte infiltration in multiple tissues (Figure 6C–E). The gastrointestinal
tract was particularly affected in aged Atg16l1DFoxp3 mice, with marked inflammation in the SI and
colon (Figure 6E,F). Intestinal inflammation in aged Atg16l1DFoxp3 mice was characterized by mas-
sive accumulation of activated CD4+ T cells in the intestinal LP and mLN (Figure 7A–D and Fig-
ure 7—figure supplement 1A). The cLP infiltrate in aged Atg16l1DFoxp3 mice contained a mixed
Kabat et al. eLife 2016;5:e12444. DOI: 10.7554/eLife.12444 12 of 27
Research article Immunology
population of TH1, TH17 and TH2 effector cells, with a significant increase in the frequencies of IL-13
+
CD4+ TH2 cells (Figure 7E,F), although this TH2 bias was not present in young Atg16l1
DFoxp3 mice
(Figure 7—figure supplement 1B). In addition, we observed increased frequencies of Gata3+ CD4+
Figure 6. Aged Atg16l1DFoxp3 mice develop spontaneous multi-organ inflammation. (A) LC3+ autophagosome formation by Foxp3- CD4+ T cells and
Foxp3+ Treg cells from cLP and mLN of WT mice in unstimulated cells or after overnight activation with a-CD3 (5 mg/ml) and a-CD28 (1 mg/ml). (B)
Representative LC3 staining of unstimulated cells (gated on Foxp3+ CD4+ TCRb+ Treg cells or Foxp3
- CD4+ TCRb+ T cells). (C) Weight curves and (D)
spleen weights and representative images of spleen and mLN of aged Atg16l1DFoxp3 and Atg16l1fl/fl littermates. (E) Representative photomicrographs
of H&E stained sections of liver, spleen, stomach, SI (jejunum), proximal colon and mid-colon of aged Atg16l1DFoxp3 and Atg16l1fl/fl littermates, scale
bar 150 mm. (F) Quantification of SI length. Data are combined from two to four independent experiments with two to five mice per group (A,D,F) or
are representative of two to three independent experiments with two to five mice per group (B,C,E). Each dot represents an individual mouse and
horizontal bars denote means (A,D,F). Data shown as mean ± s.e.m (C). Statistical significance was determined using two-way analysis of variance
(ANOVA) with Bonferroni’s correction for multiple comparisons (C) or using the Mann–Whitney test (A,D,F), *p<0.05; **p<0.01; ***p<0.001. mLN -
mesenteric lymph nodes, SI – small intestine lamina propria, cLP – colonic lamina propria. Aged mice >5 months old.
DOI: 10.7554/eLife.12444.014
The following figure supplements are available for figure 6:
Figure supplement 1. Impaired reconstitution of mixed bone marrow chimeras by Atg16l1-deficient T cells.
DOI: 10.7554/eLife.12444.015
Figure supplement 2. Analysis of Atg16l1 expression in Atg16l1DFoxp3 mice.
DOI: 10.7554/eLife.12444.016
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T cells in the spleen, mLN and cLP of aged Atg16l1DFoxp3 mice (Figure 7G). Analyses of humoral
responses in aged Atg16l1DFoxp3 mice revealed significantly elevated levels of circulating IgE and
IgA, however IgG1 levels were not increased (Figure 7H and Figure 7—figure supplement 1C).
Thus, selective ablation of Atg16l1 in Foxp3+ Treg cells led to intestinal inflammation that was charac-
terized by accumulation of all TH effector types, with a disproportionate increase in TH2 responses in
Figure 7. Atg16l1DFoxp3 mice cannot control pro-inflammatory TH effector responses. (A) Representative immunofluorescence images of small intestine
and proximal and mid colon of aged Atg16l1DFoxp3 and Atg16l1fl/fl littermates stained for CD3 (red), b-catenin (green) and DAPI (blue). (B) Frequencies
and (C) total numbers of cLP CD4+ TCRb+ T cells in aged Atg16l1DFoxp3 and Atg16l1fl/fl littermates. (D) Frequencies of effector (CD44+CD62L-) CD4+ T
cells in the mLN and cLP of aged Atg16l1DFoxp3 and Atg16l1fl/fl littermates (gated on CD4+ TCRb+ Foxp3- T cells). (E) Frequencies and (F) total numbers
of TH1 (IFN-g
+), TH17 (IL-17A
+), TH2 (IL-13
+) T cells in the cLP of aged Atg16l1DFoxp3 and Atg16l1fl/fl littermates (gated on CD4+ TCRb+ Foxp3- T cells).
(G) Frequencies of Gata3+ CD4+ T cells in aged Atg16l1DFoxp3 and Atg16l1fl/fl littermates (gated on CD4+ TCRb+ Foxp3- T cells). (H) Serum IgE
concentrations in Atg16l1DFoxp3 and Atg16l1fl/fl littermates were measured by ELISA. Data are combined from two to four independent experiments
with two to five mice per group (B-H) or are representative of two independent experiments with two to five mice per group (A). Each dot represents an
individual mouse and horizontal bars denote means. Statistical significance was determined using the Mann–Whitney test *p<0.05; **p<0.01;
***p<0.001. mLN - mesenteric lymph nodes, cLP – colonic lamina propria. Young mice: 8–12 weeks old, aged mice >5 months old.
DOI: 10.7554/eLife.12444.017
The following figure supplement is available for figure 7:
Figure supplement 1. Additional characterization of Atg16l1DFoxp3 mice.
DOI: 10.7554/eLife.12444.018
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Figure 8. Cell-intrinsic autophagy is required for metabolic adaptation and survival of intestinal Foxp3+ Treg cells.
(A) Foxp3+ Treg cell frequencies among CD4
+ TCRb+ T cells in Atg16l1DFoxp3 and Atg16l1fl/fl littermates and (B)
representative FACS plots of Foxp3 expression in cLP CD4+ T cells from young Atg16l1DFoxp3 and Atg16l1fl/fl
littermates (gated on CD4+ TCRb+ T cells). (C) qPCR analysis of glycolytic gene levels in sorted Foxp3+ Treg cells
from spleen and cLP of young Atg16l1DFoxp3 and Foxp3Cre mice (sorted for CD4+ TCRb+ YFP+). (D) qPCR analysis
of FAS and FAO gene levels in Foxp3+ Treg cells from the spleen and cLP of young Atg16l1
DFoxp3 and Foxp3Cre
mice (sorted for CD4+ TCRb+ YFP+). FAS: fatty acid synthesis, FAO: fatty acid oxidation, Glut1: glucose transporter
1, Slc16ac: solute carrier family 16 member 3 (lactic acid and pyruvate transporter), Tpi1: triosephosphate
isomerase 1, Aldo–a: aldolase a, Ldh-a: lactate dehydrogenase a, Gpi1: Glucose phosphate isomerase 1, Pgk1:
Phosphoglycerate kinase 1, Acc1: acetyl-CoA carboxylase 1, Acc2: acetyl-CoA carboxylase 2, Srebf1: sterol
regulatory element binding transcription factor 1, Srebf2: sterol regulatory element binding transcription factor 2,
Fdft1: farnesyl-diphosphate farnesyltransferase 1, Fabp: Fatty acid-binding protein. Data are representative from
Figure 8 continued on next page
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aged mice. However, the breadth and magnitude of TH2-associated responses were less pronounced
in Atg16l1DFoxp3 mice compared to those observed in Atg16l1DCD4 mice.
When we examined the Treg cell compartment in Atg16l1
DFoxp3 mice, we found significantly
decreased frequencies of Foxp3+ Treg cells in the spleen and mLN compared to Atg16l1
fl/fl litter-
mates, although thymic Treg cell frequencies were similar (Figure 8A). As found in Atg16l1DCD4 mice,
intestinal LP Foxp3+ Treg cells were severely depleted in Atg16l1
DFoxp3 mice and those remaining
exhibited significantly increased expression of effector TH cytokines (Figure 8A,B and Figure 8—fig-
ure supplement 1A). Thus, Treg cell-specific deletion of Atg16l1 recapitulated the Treg cell deficits
observed in Atg16l1DCD4 mice, showing that cell-intrinsic autophagy is essential for peripheral Treg
cell homeostasis, especially in the intestine.
Differential survival of autophagy-deficient Treg cells and TH2 cells is
associated with an altered metabolic profile
Finally, we investigated mechanisms that might underlie the striking survival defect of Atg16l1-defi-
cient intestinal Treg cells. Analyses of key regulators of apoptosis revealed that Atg16l1-deficient Treg
cells isolated from spleen and cLP had comparable expression of pro-apoptotic (Bim, Bax) and anti-
apoptotic (Bcl2) genes as those isolated from control mice (Figure 8—figure supplement 1B). As
recent evidence suggests that tissue-resident Treg cell populations may exhibit specialized metabolic
adaptations (Burzyn et al., 2013), we compared the expression of metabolic genes by WT and
Atg16l1-deficient Treg cells. Analyses of genes involved in glycolysis, fatty acid synthesis (FAS) and
fatty acid oxidation (FAO), revealed that Atg16l1-deficient Treg cells had higher expression of glyco-
lytic genes, including Glut1, Slc16a3, Tpi1, Ldh-a, Aldo-a, Gpi1 and Pgk1, than control Treg cells
(Figure 8C). Strikingly, this augmented glycolytic signature was much more pronounced in Atg16l1-
deficient Treg cells isolated from cLP versus those from the spleen (Figure 8C). Conversely, expres-
sion of many key genes involved in FAS/FAO, including Acc1, Acc2, Srebf1, Srebf2, Fdft1, Fabp1,
Fabp4 and Fabp5 was markedly decreased in Atg16l1-deficient Treg cells (Figure 8D). Again, these
differences were most pronounced in the intestine; WT cLP Treg cells showed increased FAS/FAO
gene expression compared to their spleen counterparts, whereas Atg16l1-deficient cLP Treg cells
were not able to up-regulate the expression of FAS/FAO genes (Figure 8D). Thus, Atg16l1-defi-
ciency profoundly influenced the expression of metabolic genes in intestinal Treg cells, with an
altered balance of glycolytic and FAS/FAO gene expression. Further evidence of increased reliance
on lipid metabolism by colonic Treg cells was provided by our observation that Treg cells isolated
from the cLP showed markedly increased lipid uptake in comparison to mLN or spleen Treg cells (Fig-
ure 8—figure supplement 2A,B). A similar pattern was observed when we assayed expression of
CD36, a fatty acid translocase that enhances FA uptake: colonic Treg cells showed increased expres-
sion of CD36 compared to splenic and mLN Treg cells (Figure 8—figure supplement 2C,D). Inter-
estingly, we found that Atg16l1-deficient Treg cells showed comparable levels of lipid uptake and
CD36 expression as their autophagy-sufficient counterparts (Figure 8—figure supplement 2A–D),
suggesting that autophagy does not affect lipid uptake per se but rather affects lipid metabolism.
Together, these results demonstrate that cell-intrinsic autophagy is indispensable for Foxp3+ Treg
cell maintenance and function in peripheral tissues, particularly to suppress inflammatory responses
Figure 8 continued
two (C,D) or three independent experiments (A,B). Each dot represents individual mouse (A) or data are shown as
mean ± s.e.m (C,D). Gene expression levels are shown as mean ± s.e.m of three technical replicates (C,D).
Numbers indicate percentage of cells in gates (B). cLP – colonic lamina propria. Young mice: 8–12 weeks old.
DOI: 10.7554/eLife.12444.019
The following figure supplements are available for figure 8:
Figure supplement 1. Atg16l1-deficient colonic Treg cells exhibit increased cytokine secretion.
DOI: 10.7554/eLife.12444.020
Figure supplement 2. Increased lipid uptake by intestinal Treg cells.
DOI: 10.7554/eLife.12444.021
Figure supplement 3. TH2 cells exhibit an enhanced glycolytic metabolic profile that is independent of
autophagy.
DOI: 10.7554/eLife.12444.022
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within the gastrointestinal tract. Decreased survival of Atg16l1-deficient Treg cells was associated
with an altered metabolic profile, suggesting that autophagy plays an integral role in facilitating the
metabolic adaptions required for long-term Treg cell survival in the intestine.
We next explored whether autophagy had a general effect on T cell metabolic profile and
whether this might explain the differential effects on TH2 cells and Treg cells. Evidence that this might
be the case came from our observation that Atg16l1-deficient naı¨ve CD4+ T cells exhibited increased
cell size compared with naı¨ve CD4+ T cells isolated from Atg16l1fl/fl littermates (Figure 8—figure
supplement 3A). We therefore measured oxygen consumption rate (OCR), which is an indicator of
oxidative phosphorylation (OXPHOS), and extracellular acidification rate (ECAR), an indirect indica-
tor of aerobic glycolysis. We found that Atg16l1-deficient naı¨ve CD4+ T cells exhibited significantly
increased OCR and ECAR, metabolic changes that are typically observed in activated CD4+ T cells
and are associated with increased aerobic glycolysis (Figure 8—figure supplement 3B).
As TH2 cells have previously been reported to display an increased glycolytic rate compared to
other TH subsets (Michalek et al., 2011; Yang et al., 2013), we hypothesized that they may be
more resistant to the increased glycolysis that is induced in the absence of autophagy. As it was not
possible to sort TH2 cells from the cLP, we performed this analysis on in vitro cultures of TH2 and
Treg cells. We found that TH2 cells were larger than Treg cells, expressed higher levels of c-Myc, a crit-
ical regulator of metabolic reprograming in activated T cells, and had markedly higher ECAR, all
indicative of enhanced aerobic glycolysis (Figure 8—figure supplement 3C–E). Furthermore, while
Atg16l1-deficient Treg cells showed higher expression of c-Myc, significantly increased levels of
ECAR and OCR, and were larger than their control Atg16l1-sufficient counterparts, we observed
constitutively high and comparable levels of glycolysis in Atg16l1-deficient and Atg16l1-sufficient
TH2 cells (Figure 8—figure supplement 3C–E). These patterns were recapitulated when expression
of key metabolic genes were analyzed; TH2 cells showed high expression of a panel of glycolytic
genes irrespective of their autophagy Atg16l1 genotype, whereas Treg cell expression of glycolytic
genes was generally lower, unless the Treg cells were autophagy-deficient (Figure 8—figure supple-
ment 3F). Taken together, these results suggest that the enhanced glycolytic metabolism constitu-
tively employed by TH2 cells makes them more resistant to the metabolic changes that occur in the
absence of autophagy.
Discussion
The unique challenges of the intestine necessitate complex mechanisms of tolerance and immune
regulation to maintain homeostasis (Izcue et al., 2009). As altered mucosal CD4+ T cell responses
are implicated in intestinal diseases of increasing prevalence, including food allergies and IBD
(Maloy and Powrie, 2011; Berin and Sampson, 2013), it is important to understand the factors that
control effector and regulatory T cell homeostasis in the gut. Here, we identify Atg16l1 and autoph-
agy as a new critical pathway regulating intestinal Treg and TH2 responses.
Recent studies addressing the role of autophagy in distinct leukocyte populations have
highlighted T cells as being very sensitive to perturbations in the autophagy pathway (Ma et al.,
2013). Our data extend these findings by showing that autophagy is particularly important for the
survival of CD4+ T cells within the gut environment, as Atg16l1 deletion in T cells led to a severe
reduction of CD4+ T cell numbers in the intestinal LP. This deficit was confirmed in mixed bone mar-
row chimeras, where Atg16l1-deficient CD4+ T cells failed to reconstitute the intestinal LP compart-
ment, and by the rapid outgrowth of adoptively transferred WT CD4+ T cells in the colonic LP of
Atg16l1DCD4 recipients. However, despite the reduction in intestinal CD4+ T cells, Atg16l1DCD4 mice
spontaneously developed progressive, chronic intestinal inflammation. To confirm their increased
predisposition to develop intestinal pathology, we used an experimental model of IBD triggered by
infection with Helicobacter hepaticus and concomitant treatment with anti-IL-10R mAbs (Song-
Zhao and Maloy, 2014). This model induces severe typholocolitis that is T cell dependent and dis-
plays several features of human IBD pathology and does not require any specific genetic manipula-
tion or chemical barrier disruption. We found increased intestinal pathology in Atg16l1DCD4 mice,
confirming that Atg16l1-deficient T cells could mediate potent inflammatory responses in the gut.
Thus, selective autophagy deficiency within T cells decreases the competitiveness of these cells and
simultaneously predisposes to intestinal inflammation.
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We found that Atg16l1DCD4 mice exhibited a drastic reduction in Foxp3+ Treg populations in the
cLP and SI LP, together with marked changes in intestinal Treg phenotype, including increased cell
cycling and aberrant production of TH effector cytokines. The role of autophagy in Foxp3
+ Treg cells
is not well defined. T cell-specific ablation of Vps34, which encodes a class III phosphatidylinositol 3-
kinase that promotes autophagy, resulted in decreased frequencies of Treg cells in the thymus,
spleen and lymph nodes (Parekh et al., 2013). However, as Vps34 also has autophagy-independent
functions (Backer, 2008), it was unclear as to what extent these changes were due to impaired
autophagy. Furthermore, we did not find any deficit in thymic Treg cell development in Atg16l1-defi-
cient T cells. However, we observed that Treg cells isolated from the mLN and colonic LP had
increased levels of autophagy compared to effector T cells, suggesting that autophagy is particularly
important for the maintenance of Treg cells in the periphery. Indeed, we demonstrated that cell-
intrinsic autophagy is indispensible for the maintenance and function of Foxp3+ Tregcells in the gas-
trointestinal tract, as selective deletion of Atg16l1 in the Foxp3+ Treg compartment in Atg16l1
DFoxp3
mice led to a loss of intestinal Foxp3+ Treg cells and to severe inflammation of the small intestine
and colon. In this context, it is pertinent that rapamycin, which induces autophagy through its inhibi-
tory activity on mTOR, has been shown to promote expansion of Treg cells in vitro and in vivo
(Pollizzi and Powell, 2015). Similarly, several small-molecule inducers of autophagy were shown to
selectively promote the development of Treg cells in vitro (Shaw et al., 2013). Taken together with
our findings, these observations suggest that boosting autophagy may represent a rational thera-
peutic approach to enhance Treg responses in the intestine.
How does autophagy intrinsically regulate Treg cell homeostasis? Our data indicate that autoph-
agy is not required for the differentiation of Foxp3+ Treg cells in vitro or in vivo for thymic generation
of Treg cells in vivo. However, we found that Atg16l1-deficient Treg cells showed significantly
decreased survival compared to WT Treg cells both in vitro and in vivo. As recent evidence indicates
that Treg cells utilize a distinct metabolic program that favors lipid oxidation for energy provision
(MacIver et al., 2013), one potential explanation is that autophagy regulates Treg cell metabolism
and thereby their survival. Indeed, we found that Atg16l1-deficient Treg cells expressed a distinct
metabolic profile to their WT counterparts, exhibiting increased expression of genes involved in gly-
colysis and reduced expression of genes involved in FAS/FAO. Fatty acid metabolism is emerging as
a potent regulator of T cell responses and preferential utilization of FAO has been linked to Treg cell
induction (Lochner et al., 2015). Although a recent report indicated that de novo FAS was not
required for Foxp3+ Treg cell differentiation (Berod et al., 2014), optimal in vivo Treg cell function
was associated with intrinsic lipid synthesis (Zeng et al., 2013). Furthermore, autophagy has been
implicated in the regulation of fatty acid metabolism (Singh et al., 2009; Lizaso et al., 2013;
Kaur and Debnath, 2015) and recent studies found that autophagy plays a key role in the genera-
tion of CD8+ memory T cells (Puleston et al., 2014; Xu et al., 2014), which are heavily dependent
on FAO for survival (Pearce et al., 2009; O’Sullivan et al., 2014). Thus, autophagy could play a simi-
lar survival role in Treg cells, by facilitating the degradation of intracellular lipid stores to release FAs
that fuel FAO. Additionally, as degradation of intracellular lipids by autophagy is important to avoid
lipotoxicity (Galluzzi et al., 2014), defective autophagy could lead to a toxic build up of intracellular
lipids in intestinal Treg cells.
The imbalance between glycolysis and FAS/FAO observed in autophagy-deficient Treg cells could
indicate that these cells have stalled in the activated/effector state and are unable to make the meta-
bolic adaptations necessary for long-term survival. This is supported by our data showing that a
higher proportion of autophagy-deficient Treg cells appear to be in cell cycle, but they have reduced
expression of terminal differentiation markers. Consistent with our findings, a recent study reported
that autophagy deficiency in Treg cells resulted in increased mTORC1 activation and glycolysis, lead-
ing to phenotypic instability, including expression of pro-inflammatory cytokines (Wei et al., 2016).
However, the molecular mechanism behind decreased survival of autophagy-deficient Treg cells was
not elucidated (Wei et al., 2016). It is striking that autophagy deficiency had a more detrimental
effect on intestinal Treg cells than on those found in secondary lymphoid organs. Recent evidence
suggests that tissue-resident Treg cells undergo tissue-specific adaptations, and metabolic changes
are emerging as an important facet of such reprogramming (Burzyn et al., 2013; Liston and Gray,
2014). Taken together, our results suggest that autophagy endows intestinal Treg cells with the met-
abolic flexibility required to survive in the gut tissue, where essential growth factors may be in short
supply (Pearce et al., 2013).
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Paralleling decreased Treg responses in Atg16l1
DCD4 mice, we observed a selective expansion of
TH2 cells in the intestinal LP that was already present in young mice and preceded the onset of overt
pathology. Our subsequent analyses indicated that autophagy limits mucosal TH2 cells through both
cell-intrinsic and cell-extrinsic (Treg-mediated) regulation. One possibility is that Atg16l1-deficient
TH2 cells may be somewhat resistant to Treg suppression. However, when we reconstituted pTreg
cells in Atg16l1DCD4 mice we observed a negative correlation between the numbers of intestinal Treg
cells and TH2 cells (data not shown), suggesting that autophagy-deficient TH2 cells are partially con-
trolled by Treg cells. Our data strongly suggest that the intrinsic survival advantage of Atg16l-defi-
cient TH2 cells is primarily responsible for their outgrowth in the intestine. Indeed, we observed
increased survival of Atg16l1-deficient TH2 cells in vitro, suggesting that autophagy might directly
inhibit TH2 cell expansion. This concept is consistent with a previous study that reported enhanced
survival of TH2 cells in vitro when autophagy was inhibited and that autophagy mediated death of
TH2 cells during growth-factor withdrawal (Li et al., 2006). However, we provide evidence for an
additional mechanism that could explain the preferential expansion of Atg16l1-deficient TH2 cells in
the intestine, related to the unique ability of TH2 cells to cope with prolonged high levels of glycoly-
sis. Our data contribute to accumulating evidence that a shift toward glycolysis is a general phenom-
enon observed when the autophagy pathway is perturbed in T cells. We observed characteristic
signs of increased glycolysis in Atg16l1-deficient naı¨ve CD4+ T cells and Treg cells, such as increases
in cell size, c-Myc levels and expression of glycolytic genes, as well as elevated ECAR. Others have
reported a similar glycolytic shift in autophagy-deficient CD8+ memory T cells (Puleston et al.,
2014) and Treg cells (Wei et al., 2016). Interestingly, TH2 cells have previously been shown to display
an increased glycolytic rate compared to other TH subsets (Michalek et al., 2011; Yang et al.,
2013). We confirmed the high levels of constitutive glycolysis in TH2 cells and showed that these
were comparable in Atg16l1-deficient and control TH2 cells. Moreover, Gata3 activation was previ-
ously linked to induction of glycolysis after TCR activation in T cells, through induction of c-Myc, a
critical regulator of metabolic reprograming (Wang et al., 2011; Wang et al., 2013; Wan, 2014).
We therefore propose that in TH2 cells Gata3 orchestrates metabolic adaptations that enable these
cells to cope with prolonged high levels of glycolysis, thus making them resistant to metabolic
changes enforced by autophagy deficiency. Overall, our results indicate that autophagy is a key
pathway through which TH2 responses are restrained in vivo. A lack of this restraint leads to a grad-
ual loss of tolerance to intestinal antigens, as the excessive TH2 responses in Atg16l1
DCD4 mice led
to production of IgG1 and IgA antibodies toward commensal microbiota and dietary antigens that
increased with age. Furthermore, Atg16l1DCD4 mice developed very high levels of circulating IgE,
and mounted de novo IgE antibody responses toward introduced dietary antigen.
As polymorphisms in autophagy genes are linked to IBD susceptibility, our results point towards
a novel mechanism that links impaired autophagy to intestinal inflammation through dysregulation
of mucosal T cell responses. Previous studies focused on the role of ATG16L1 and autophagy in
myeloid cells and the intestinal epithelium. They suggested that impaired autophagy could result in
reduced intestinal barrier integrity due to impaired Paneth cell function within the intestinal epithelial
layer and elevated cytokine responses by macrophages and dendritic cells (Cadwell et al., 2008;
Saitoh et al., 2008; Lassen et al., 2014). Our data add a further layer to the control of intestinal
homeostasis by autophagy, by showing that autophagy impairment alters the local T cell compart-
ment and promotes T cell driven intestinal pathology. We present compelling evidence that autoph-
agy deficiency in Treg cells leads to a deficit in intestinal Treg cells and the development of severe
intestinal pathology. Although the contribution of the TH2 axis to IBD remains unclear
(Strober et al., 2002; Shale et al., 2013), polymorphisms in IL-4, IL-5 and IL-13 have been impli-
cated by GWAS in both CD and UC (Van Limbergen et al., 2014) and elevated levels of antibodies
recognizing food and commensal antigens have been detected in IBD patients (Lodes et al., 2004;
Cai et al., 2014). Moreover, as defective Treg and increased TH2 responses at the mucosa are
observed in food allergies and asthma, our findings might also have implications for these condi-
tions. Indeed, epidemiological studies show an overlap between IBD and TH2 driven diseases, such
as atopic dermatitis and asthma (Lees et al., 2011). Furthermore, polymorphisms in the essential
autophagy gene Atg5 have recently been implicated in asthma susceptibility (Martin et al., 2012;
Poon et al., 2012). Autophagy is an attractive therapeutic target and several autophagy modulating
compounds are already in clinical trials for the treatment of various disorders (Jiang and Mizushima,
2014). Furthermore, natural dietary-derived compounds, including retinoid acid (Isakson et al.,
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2010) and vitamin D (Yuk et al., 2009), have been shown to enhance autophagy. Taken together
with our results, these findings raise the possibility that activation of autophagy through dietary or
pharmacological modulation might have beneficial effects in disorders with a signature of decreased
Treg and elevated TH2 responses, including intestinal inflammation and various hypersensitivities.
Materials and methods
Mice
Atg16l1fl/fl mice were generated and provided by the H. Virgin laboratory (Washington University,
Saint Louis, MO), as described (Hwang et al., 2012). Atg16l1fl/fl mice were crossed to B6.Cg-Tg
(Cd4-cre)1Cwi/BfluJ (CD4-Cre mice) and B6.129(Cg)-Foxp3tm4(YFP/cre)Ayr/J (Foxp3Cre mice, Jackson
Laboratory, Bar Harbor, ME) to generate Atg16l1DCD4 and Atg16l1DFoxp3 mice, respectively. All
above strains, together with B6.SJL-CD45.1 (CD45.1+), B6 Rag1-/- (Jackson Laboratory), and B6
Foxp3hCD2 mice (Komatsu et al., 2009) were bred and maintained under specific pathogen-free
conditions. Unless stated otherwise, mice were analyzed at 8–12 weeks (young mice) or > 5 months
of age (aged mice). In the gene expression analysis Atg16l1DFoxp3 mice and Foxp3Cre mice were co-
housed and age- and sex- matched. In all other experiments mice used were age- and sex-matched
littermates that were kept co-housed throughout the experiments.
T cell-mediated colitis
Experimental T cell-mediated colitis was induced by infection with Helicobacter hepaticus and con-
comitant IL-10R blockade as described (Song-Zhao and Maloy, 2014). Briefly, mice were infected
with H.hepaticus (108 CFU per mouse) by oral gavage on three consecutive days and anti-IL-10R
mAb (1B1.2) was administrated via i.p. injection (1 mg per mouse) on the first and seventh day of
the infection. Mice were sacrificed 2 weeks after colitis induction.
Histological assessment of intestinal inflammation
Mice were euthanized at indicated time points whereupon tissue sections were fixed in buffered
10% formalin and paraffin-embedded. Sections were then cut and stained with hematoxylin and
eosin. Histological analysis of intestinal inflammation was performed as described (Song-Zhao and
Maloy, 2014). Briefly, inflammation was graded semi-quantitatively on a scale from 0 to 3, for four
criteria; (a) epithelial hyperplasia and goblet cell depletion, (b) lamina propria leukocyte infiltration,
(c) area of tissue affected, and (d) markers of severe inflammation, including crypt abscesses, sub-
mucosal inflammation, and ulceration. Scores for individual criteria were totaled for an overall inflam-
mation score between 0 and 12.
Isolation of cells and flow cytometry analysis
Cell suspensions were prepared from the thymus, spleen, mLN, bone marrow and intestinal lamina
propria as previously described (Uhlig et al., 2006). The following antibodies from eBioscience (Hat-
field, UK) were used: anti-CD16/32 (93), anti-CD4 (GK1.5), anti-CD8a (53.6.7), anti-TCRb (H57-597),
anti-CD45 (30-F11), anti-CD44 (1M7), anti-CD62L (MEL-14), anti-CD45.1 (A20), anti-CD45.2 (104),
anti-CD103 (2E7)), anti-CD69 (H1.2F3), anti-KLRG1 (2F1), anti-CD25 (7D4), anti-CD36 (No.72–1),
anti-hCD2 (RPA-2.10), anti-CTLA4 (UC10-4B9), anti-GR.1 (RB6-8C5), anti-CD11b (M1/70), anti-Siglec
F (E50-2440), anti-Gata3 (TWAJ), anti-Foxp3 (FJK-16s), anti-Ki67 (SolA15), anti-Helios (22F6), anti-
Bcl2 (10C4), anti-PS6 (cupk43k), anti-IFN-g (XMG1.2), anti-IL-17A (eBio17B7), anti-IL-13 (eBio13A).
The following antibodies were from BioLegend (San Diego, CA): anti-CD138 (281–2), anti-CD161
(PK136), anti-F4/80 (BMB), anti-CD11b (M1/70). The following antibodies were from BD Biosciences
(San Jose, CA): anti-B220 (RA3 6B2), anti-GL7 (GL7), anti-CD95 (Jo2), anti-CD3 (145-2C11), anti-
CD19 (1D3), anti-Ly6C (AL-21), anti-Ly6G (1A8), anti-IgM (R6-60.2), anti-IgG1 (A85-1). Anti-c-Myc
antibody was from Cell Signaling Technology (D84C12, Danvers, MA). Anti-Neuropilin1 polyclonal
antibody was from R&D Systems (FAB566A, Minneapolis, MN). Fixable Viability Dye from eBio-
science was used to stain dead cells. Annexin V staining was performed using eBioscience kit (88–
08006) according to manufacture instructions. For intracellular cytokine staining cells were stimulated
for 3h with PMA (100ng/ml) and Ionomycin (1 mg/ml) in the presence of Brefeldin A (10 mg/ml).
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Autophagosome formation detection by flow cytometry was performed using FlowCellect
Autophagy LC3 Antibody-based Assay Kit (FCCH100171, Merk-Millipore, Billerica, MA) according to
the manufacturer’s instructions and following cell surface markers staining. The Autophagy LC3 Anti-
body-based Assay Kit involves a permeabilization step to wash out cytosolic LC3-I, allowing for anti-
body-based detection of membrane bound LC3-II. For autophagy detection in WT Treg cells B6
Foxp3hCD2 were used, as this allowed the detection of Foxp3+ Treg cells on the basis of surface
expression of hCD2 marker. All data were acquired using a Cyan ADP (Beckman Coulter, High
Wycombe, UK) and analyzed using FlowJo software (Tree Star, Ashland, OR).
CD4+ T cell purification
Bulk CD4+ T cells were purified from the spleen and mLN by negative selection as previously
described (Coccia et al., 2012). Naı¨ve CD4+ T cells were then sorted as CD4+ CD25- CD44-
CD62L+. Treg cells were sorted as CD4
+ CD25+ when sorted from Atg16l1DCD4 and Atg16l1fl/fl mice
and as CD4+ YFP+ when sorted from Atg16l1DFoxp3 and Foxp3Cre mice. Cells were sorted using an
Astrios, Beckman Coulter MoFlo XDP or AriaIII BD Bioscience. Post-sort flow cytometry analyses con-
firmed that the purity of sorted populations was >97%.
Adoptive transfer of naı¨ve CD4+ T cells
Naı¨ve CD4+ T cells from WT (CD45.1+) mice were sorted as described above and transferred to
Atg16l1DCD4 recipient (CD45.2+) mice via intravenous injection (4-5x106 cells per mouse). Analysis of
spleen, mLN and cLP CD4+ T and Treg cells was performed 3 months after transfer.
Generation of mixed bone marrow chimeras
BM cells were isolated from the tibia and femur of WT (CD45.1+) mice and Atg16l1fl/fl or
Atg16l1DCD4 (CD45.2+) mice and injected i.v. at 1:1 ratio (a total of 1x107 cells per mouse) into
lethally irradiated (1100 Rad, split dose) Rag1-/- recipients. Mice were allowed to reconstitute for at
least 8 weeks before analysis.
Immunization with ovalbumin (OVA)
For induction of OVA-specific IgE antibodies two treatment regimes were utilized. For OVA only
immunization mice were fed three times by oral gavage with ovalbumin grade VII (5 mg per mouse,
Sigma-Aldrich, St Louis, MO) with 21-day intervals between feeds. For adjuvanted immunization,
mice were initially fed with OVA (5 mg per mouse) plus cholera toxin (10 mg per mouse, Biologial
Compbell), after which they were fed twice with OVA only (5mg per mouse), with 21-day intervals
between feeds.
Infection with Trichuris muris and detection of T. muris-specific IgG1
Mice were orally infected with ~200 Trichuris muris eggs. Serum was collected on day 34-post infec-
tion and assayed by ELISA for parasite-specific IgG1. Ninety-six-well plates were coated with 5 mg/ml
T. muris excretory/secretory antigen and incubated with serial two-fold diluted serum. Bound IgG1
was detected using biotinylated anti-murine IgG1 (AbD Serotec, Kidlington, UK).
Lipid uptake measurement
Atg16l1fl/fl and Atg16l1DCD4 mice were injected i.p. with 50 mg of fluorescent 16-carbon fatty acid
analog BODIPY C-16 (Molecular Probes) reconstituted in DMSO. Mice were culled 1 hr later and tis-
sue collected for analysis by flow cytometry.
Metabolic analysis using XF 96 extracellular flux analyzer
The real-time extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) were mea-
sured using a XF 96 extracellular flux analyzer (Seahorse Bioscience, Billerica, MA). Briefly, naı¨ve
(CD62L+CD44-) CD4+ T cells, or in vitro polarized TH2 and Treg cells, were washed twice in assay
medium (RPMI 1640 without sodium bicarbonate, 20 mM glucose, 1% FCS, 2mM pyruvate) and
seeded at 3–4 x 105 cells per well in assay medium in a 96-well XF plate coated with poly-L-lysine
(Sigma). T cells were rested for 1 hr at 37˚C without CO2 before analysis.
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Polarization and stimulation of CD4+ T cell subsets
Naı¨ve CD4+ T cells were cultured (3x105 cells/well) in 96-well plates coated with anti-CD3 mAb
(5 mg/ml) and soluble anti-CD28 mAb (1 mg/ml) and kept in presence of IL-2 (100 U/ml). For TH0 con-
ditions anti-IL-4 (10 mg/ml) and anti-IFN-g (10 mg/ml) mAb were added. Cultures were supplemented
with IL-12 (10 ng/ml) and anti-IL-4 mAb (10 mg/ml) for TH1 polarization; with IL-4 (20 ng/ml), anti-
IFN-g (20 mg/ml) and anti-IL-12 (10 mg/ml) for TH2 polarization; and with TGF-b1 (5 ng/ml), anti-IFN-
g, anti-IL-4 mAb and anti-IL-12 (all 10 mg/ml) for induced Treg polarization. Sorted Treg cells were acti-
vated for 48h with anti-CD3 mAb (5 mg/ml) and soluble anti-CD28 mAb (1 mg/ml) plus IL-2 (100 U/
ml) and then cultured with IL-4 (10 ng/ml), IL-13 (10 ng/ml) and IL-2 (100 U/ml) for 5 days. All cyto-
kines were from R&D Systems. Anti-CD3 (145-2C11), anti-CD28 (37.51), anti-IFN-g (XMG1.2), anti-IL-
12 (C17.8) and anti-IL-4 (11B11) mAb were from eBioscience. Cells were cultured in RPMI-1640
Medium, 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml of Penicillin/Streptomycin, and 0.05 mM
2-mercaptoethanol.
Measurement of serum antibodies and cytokines
All immunoglobulin isotypes except for IgE were measured by enzyme-linked immunosorbent assay
(ELISA) using the SBA Clonotyping System (Southern Biotech, Birmingham, AL). IgE concentration
was determined using an anti-mouse IgE ELISA (BioLegend), according to manufacturer’s instruc-
tions. For the detection of soy-specific, CBir-specific and Helicobacter-specific antibodies ELISA was
performed with plates coated with purified soy antigen (5 mg/ml), CBir peptide (10 mg/ml) and solu-
ble Helicobacter antigen (sHel antigen, 10 mg/ml) respectively. sHel antigen was prepared as previ-
ously described (Kullberg et al., 1998). For the detection of OVA-specific IgE, a sandwich ELISA
was performed with biotinylated-OVA used for detection. MCPT-1 concentrations were measured
by ELISA (eBioscience).
Immunofluorescence microscopy
Colonic and small intestine tissue samples were formalin-fixed, paraffin-embedded and sectioned as
per histological analysis. Sections were deparaffinized, rehydrated, and subjected to sodium citrate-
based antigen retrieval, then stained with mouse pAb anti-b-catenin (610153, BD Bioscience), rabbit
pAb anti-CD3 (ab5690, Abcam, Cambridge, UK) and secondary goat antibodies conjugated to Alex-
aFluor488 or 555 (Life Technologies, Carlsbad, CA). Slides were mounted with DAPI-containing Vec-
tashield (Vector Laboratories, Burlingame, CA). Images were acquired with an Olympus Fluoview
FV1000 confocal microscope and Olympus Fluoview Software (Olympus, Tokyo, Japan).
Western blotting analysis
CD4+ T cells purified by negative selection were lysed in RIPA buffer containing protease inhibitor
cocktail (Roche, Basel, Switzerland). Protein levels were normalized by Biorad DC protein assay (Bio-
Rad Laboratories, Hercules, CA), resolved by SDS-PAGE and, following transfer onto nitrocellulose
membranes, were blotted with anti-LC3 antibody (L7543; Sigma-Aldrich) and anti-tubulin antibody
(sc5286, Santa Cruz Biotechnology, Dallas, TX), and secondary HRP conjugated anti–rabbit antibody
(7074S, Cell Signaling Technology).
Fluidigm gene expression analysis
CD4+ T cells and Treg cells were sorted for each population based on surface marker and YFP
expression from spleen and cLP of Atg16l1DFoxp3 and Foxp3Cre mice. Two hundred cells/population
were sorted in triplicates from a total of four (spleen) or six (cLP) mice per group. Alternatively, 250
cells from in vitro polarized populations of TH2 and Treg cells were sorted from triplicate culture
wells. RNA was reverse transcribed and cDNA was pre-amplified using the CellsDirect OneStep q-
RT kit (Invitrogen). The selected autophagy, apoptotic and metabolic genes were amplified and ana-
lyzed for expression using a dynamic 48x48 array (Biomark Fluidigm) as previously described
(Tehranchi et al., 2010). Data were analyzed using the 2-DCt method, and the results were normal-
ized to actin or HPRTprt expression.
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Statistical analysis
For weight curves and antibody titers, p-values were determined by two-way ANOVA with Bonfer-
roni post-tests. For the metabolic analysis using XF 96 extracellular flux analyzer, p-values were
determined using unpaired Student’s t-test. For all other experiments, p-values were determined by
nonparametric Mann–Whitney test. Differences were considered statistically significant when p<0.05
(*<p0.05, **p<0.01, ***p<0.001). Data are shown as mean ± s.e.m. Statistics were calculated using
GraphPad Prism 6 software. For in vivo experiments, sample size was determined by power analysis
using power of trial software, which calculates a power value based on X2 test statistics. Calculated
required sample sizes were applied whenever possible. No mouse was excluded from the analysis.
With the exception of histological assessment of intestinal inflammation, experimenters were not
’blinded’ to allocation of animals to experimental groups.
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